Skip to main content
DBD logo

DBD · DIEBOLD NIXDORF, Inc

Track DBD — free
Market Cap
$2.29B
Shares
33.95M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$200,000,000
as of 2026-07-29 · from 8-K (reviewed)
Remaining Authorization
$57,000,000
as of 2026-07-29 · from 8-K (reviewed)
Program Utilization
71.5% $143,000,000 used of $200,000,000
Program Announced Authorized Remaining Runs Through
2026-02-12 $200,000,000 $57,000,000
2025-11-05 $200,000,000
$100,000,000 $62,000,000

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-06-30 YTD $121,000,000
2025-12-31 $130,700,000
2024-12-31 $0
2022-12-31 $7,800,000
2021-12-31 $7,700,000
2020-12-31 $6,600,000
2019-12-31 $1,900,000
2018-12-31 $3,000,000
2017-12-31 $5,000,000
2016-12-31 $2,200,000
2015-12-31 $3,000,000
2014-12-31 $1,900,000
2013-12-31 $4,100,000
2012-12-31 $3,452,000
2011-12-31 $111,815,000
2010-12-31 $25,769,000
2009-12-31 $1,918,000
Key facts CIK 28823 CUSIP 253651202 13F (30d) 181 filings 180 filers Visit website Investor relations